Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
Gespeichert in:
Veröffentlicht in: | Nature medicine 2024-06, Vol.30 (6), p.1784-1784 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1784 |
---|---|
container_issue | 6 |
container_start_page | 1784 |
container_title | Nature medicine |
container_volume | 30 |
creator | Wadden, Thomas A. Chao, Ariana M. Machineni, Sriram Kushner, Robert Ard, Jamy Srivastava, Gitanjali Halpern, Bruno Zhang, Shuyu Chen, Jiaxun Bunck, Mathijs C. Ahmad, Nadia N. Forrester, Tammy |
description | |
doi_str_mv | 10.1038/s41591-024-02883-1 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11186756</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3069699729</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3901-971f26d0c7f3252d38a2aad9bb52b58425a2631fb9e797f1ed5aedb710486c573</originalsourceid><addsrcrecordid>eNp9kctu1DAUhi0Eou3AC7BAltiwCfgSx3Y3qBq1FKlQCWYkdpaTnExcZeLBdqaaPgGPXbdTymXBwvLlfP9vH_8IvaLkHSVcvY8lFZoWhJV5KMUL-gQdUlFWBZXk-9O8JlIVSovqAB3FeEUI4UTo5-iAq5Joofkh-nkypd4HPPchQJOcH4_xwoUb2NjkWsC2SxCwGxOM0W0BD66DmHYD3J-FLYx3mrzBtp2GFPG1Sz32WwjX4FZ9wtnb1xBd2h3j1AP-tvz6-XL5ZVFwvOltBMxxCs4OL9Czzg4RXj7MM7Q8O13Mz4uLy4-f5icXRcM1oYWWtGNVSxrZcSZYy5Vl1ra6rgWrhSqZsKzitKs1SC07Cq2w0NaSklJVjZB8hj7sfTdTvYa2yQ0EO5hNcGsbdsZbZ_6ujK43K781lFJVSVFlh7cPDsH_mPJvmLWLDQyDHcFP0TDNWck5UTyjb_5Br_wUxtyf4aTSldYy0zPE9lQTfIwBusfXUGLukjb7pE1O2twnbWgWvf6zj0fJr2gzwPdAzKVxBeH33f-xvQW36LZb</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3069699729</pqid></control><display><type>article</type><title>Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial</title><source>Nature</source><source>SpringerLink Journals - AutoHoldings</source><creator>Wadden, Thomas A. ; Chao, Ariana M. ; Machineni, Sriram ; Kushner, Robert ; Ard, Jamy ; Srivastava, Gitanjali ; Halpern, Bruno ; Zhang, Shuyu ; Chen, Jiaxun ; Bunck, Mathijs C. ; Ahmad, Nadia N. ; Forrester, Tammy</creator><creatorcontrib>Wadden, Thomas A. ; Chao, Ariana M. ; Machineni, Sriram ; Kushner, Robert ; Ard, Jamy ; Srivastava, Gitanjali ; Halpern, Bruno ; Zhang, Shuyu ; Chen, Jiaxun ; Bunck, Mathijs C. ; Ahmad, Nadia N. ; Forrester, Tammy</creatorcontrib><identifier>ISSN: 1078-8956</identifier><identifier>ISSN: 1546-170X</identifier><identifier>EISSN: 1546-170X</identifier><identifier>DOI: 10.1038/s41591-024-02883-1</identifier><identifier>PMID: 38409593</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>692/163/2743/393 ; 692/699/317 ; Author ; Author Correction ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Infectious Diseases ; Metabolic Diseases ; Molecular Medicine ; Neurosciences</subject><ispartof>Nature medicine, 2024-06, Vol.30 (6), p.1784-1784</ispartof><rights>The Author(s) 2024</rights><rights>The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3901-971f26d0c7f3252d38a2aad9bb52b58425a2631fb9e797f1ed5aedb710486c573</citedby><orcidid>0009-0000-4712-3225 ; 0000-0002-1643-6795 ; 0000-0002-0438-4609</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41591-024-02883-1$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41591-024-02883-1$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38409593$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wadden, Thomas A.</creatorcontrib><creatorcontrib>Chao, Ariana M.</creatorcontrib><creatorcontrib>Machineni, Sriram</creatorcontrib><creatorcontrib>Kushner, Robert</creatorcontrib><creatorcontrib>Ard, Jamy</creatorcontrib><creatorcontrib>Srivastava, Gitanjali</creatorcontrib><creatorcontrib>Halpern, Bruno</creatorcontrib><creatorcontrib>Zhang, Shuyu</creatorcontrib><creatorcontrib>Chen, Jiaxun</creatorcontrib><creatorcontrib>Bunck, Mathijs C.</creatorcontrib><creatorcontrib>Ahmad, Nadia N.</creatorcontrib><creatorcontrib>Forrester, Tammy</creatorcontrib><title>Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial</title><title>Nature medicine</title><addtitle>Nat Med</addtitle><addtitle>Nat Med</addtitle><subject>692/163/2743/393</subject><subject>692/699/317</subject><subject>Author</subject><subject>Author Correction</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Infectious Diseases</subject><subject>Metabolic Diseases</subject><subject>Molecular Medicine</subject><subject>Neurosciences</subject><issn>1078-8956</issn><issn>1546-170X</issn><issn>1546-170X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><recordid>eNp9kctu1DAUhi0Eou3AC7BAltiwCfgSx3Y3qBq1FKlQCWYkdpaTnExcZeLBdqaaPgGPXbdTymXBwvLlfP9vH_8IvaLkHSVcvY8lFZoWhJV5KMUL-gQdUlFWBZXk-9O8JlIVSovqAB3FeEUI4UTo5-iAq5Joofkh-nkypd4HPPchQJOcH4_xwoUb2NjkWsC2SxCwGxOM0W0BD66DmHYD3J-FLYx3mrzBtp2GFPG1Sz32WwjX4FZ9wtnb1xBd2h3j1AP-tvz6-XL5ZVFwvOltBMxxCs4OL9Czzg4RXj7MM7Q8O13Mz4uLy4-f5icXRcM1oYWWtGNVSxrZcSZYy5Vl1ra6rgWrhSqZsKzitKs1SC07Cq2w0NaSklJVjZB8hj7sfTdTvYa2yQ0EO5hNcGsbdsZbZ_6ujK43K781lFJVSVFlh7cPDsH_mPJvmLWLDQyDHcFP0TDNWck5UTyjb_5Br_wUxtyf4aTSldYy0zPE9lQTfIwBusfXUGLukjb7pE1O2twnbWgWvf6zj0fJr2gzwPdAzKVxBeH33f-xvQW36LZb</recordid><startdate>20240601</startdate><enddate>20240601</enddate><creator>Wadden, Thomas A.</creator><creator>Chao, Ariana M.</creator><creator>Machineni, Sriram</creator><creator>Kushner, Robert</creator><creator>Ard, Jamy</creator><creator>Srivastava, Gitanjali</creator><creator>Halpern, Bruno</creator><creator>Zhang, Shuyu</creator><creator>Chen, Jiaxun</creator><creator>Bunck, Mathijs C.</creator><creator>Ahmad, Nadia N.</creator><creator>Forrester, Tammy</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0009-0000-4712-3225</orcidid><orcidid>https://orcid.org/0000-0002-1643-6795</orcidid><orcidid>https://orcid.org/0000-0002-0438-4609</orcidid></search><sort><creationdate>20240601</creationdate><title>Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial</title><author>Wadden, Thomas A. ; Chao, Ariana M. ; Machineni, Sriram ; Kushner, Robert ; Ard, Jamy ; Srivastava, Gitanjali ; Halpern, Bruno ; Zhang, Shuyu ; Chen, Jiaxun ; Bunck, Mathijs C. ; Ahmad, Nadia N. ; Forrester, Tammy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3901-971f26d0c7f3252d38a2aad9bb52b58425a2631fb9e797f1ed5aedb710486c573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>692/163/2743/393</topic><topic>692/699/317</topic><topic>Author</topic><topic>Author Correction</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Infectious Diseases</topic><topic>Metabolic Diseases</topic><topic>Molecular Medicine</topic><topic>Neurosciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wadden, Thomas A.</creatorcontrib><creatorcontrib>Chao, Ariana M.</creatorcontrib><creatorcontrib>Machineni, Sriram</creatorcontrib><creatorcontrib>Kushner, Robert</creatorcontrib><creatorcontrib>Ard, Jamy</creatorcontrib><creatorcontrib>Srivastava, Gitanjali</creatorcontrib><creatorcontrib>Halpern, Bruno</creatorcontrib><creatorcontrib>Zhang, Shuyu</creatorcontrib><creatorcontrib>Chen, Jiaxun</creatorcontrib><creatorcontrib>Bunck, Mathijs C.</creatorcontrib><creatorcontrib>Ahmad, Nadia N.</creatorcontrib><creatorcontrib>Forrester, Tammy</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nature medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wadden, Thomas A.</au><au>Chao, Ariana M.</au><au>Machineni, Sriram</au><au>Kushner, Robert</au><au>Ard, Jamy</au><au>Srivastava, Gitanjali</au><au>Halpern, Bruno</au><au>Zhang, Shuyu</au><au>Chen, Jiaxun</au><au>Bunck, Mathijs C.</au><au>Ahmad, Nadia N.</au><au>Forrester, Tammy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial</atitle><jtitle>Nature medicine</jtitle><stitle>Nat Med</stitle><addtitle>Nat Med</addtitle><date>2024-06-01</date><risdate>2024</risdate><volume>30</volume><issue>6</issue><spage>1784</spage><epage>1784</epage><pages>1784-1784</pages><issn>1078-8956</issn><issn>1546-170X</issn><eissn>1546-170X</eissn><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>38409593</pmid><doi>10.1038/s41591-024-02883-1</doi><tpages>1</tpages><orcidid>https://orcid.org/0009-0000-4712-3225</orcidid><orcidid>https://orcid.org/0000-0002-1643-6795</orcidid><orcidid>https://orcid.org/0000-0002-0438-4609</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1078-8956 |
ispartof | Nature medicine, 2024-06, Vol.30 (6), p.1784-1784 |
issn | 1078-8956 1546-170X 1546-170X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11186756 |
source | Nature; SpringerLink Journals - AutoHoldings |
subjects | 692/163/2743/393 692/699/317 Author Author Correction Biomedical and Life Sciences Biomedicine Cancer Research Infectious Diseases Metabolic Diseases Molecular Medicine Neurosciences |
title | Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T13%3A35%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Author%20Correction:%20Tirzepatide%20after%20intensive%20lifestyle%20intervention%20in%20adults%20with%20overweight%20or%20obesity:%20the%20SURMOUNT-3%20phase%203%20trial&rft.jtitle=Nature%20medicine&rft.au=Wadden,%20Thomas%20A.&rft.date=2024-06-01&rft.volume=30&rft.issue=6&rft.spage=1784&rft.epage=1784&rft.pages=1784-1784&rft.issn=1078-8956&rft.eissn=1546-170X&rft_id=info:doi/10.1038/s41591-024-02883-1&rft_dat=%3Cproquest_pubme%3E3069699729%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3069699729&rft_id=info:pmid/38409593&rfr_iscdi=true |